Gsa Capital Partners LLP Gilead Sciences, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$71.58 - $87.29 $451,097 - $550,101	6,302 New	6,302 $461,000
Q3 2023 Nov 15, 2023	BUY	$73.94 - $80.67 $266,405 - $290,654	3,603 New	3,603 $270,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $210,205 - $239,489	2,719 New	2,719 $225,000
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $431,052 - $485,494	-7,468 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $432,546 - $542,027	7,468 New	7,468 $444,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $223,316 - $253,468	-3,442 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $232,988 - $251,369	3,442 New	3,442 $240,000
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $465,996 - $509,167	-7,342 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $440,520 - $502,633	7,342 New	7,342 $475,000
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $510,643 - $581,853	-9,014 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $559,769 - $703,813	9,014 New	9,014 $570,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $360,936 - $462,307	-5,763 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $493,329 - $542,646	-8,006 Reduced 58.15%	5,763 $374,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $288,046 - $317,952	-4,608 Reduced 25.07%	13,769 $873,000
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $171,379 - $192,182	-2,770 Reduced 13.1%	18,377 $1.24 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $136,190 - $152,568	-2,178 Reduced 9.34%	21,147 $1.38 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $56,241 - $73,391	929 Added 4.15%	23,325 $1.46 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $1.44 Million - $1.6 Million	-20,216 Reduced 47.44%	22,396 $1.73 Million
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $443,065 - $516,818	-6,829 Reduced 13.81%	42,612 $3.02 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $3.76 Million - $4.58 Million	-51,563 Reduced 51.05%	49,441 $3.73 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $6.81 Million - $8 Million	95,761 Added 1826.45%	101,004 $7.24 Million
Q3 2017 Nov 20, 2017	BUY	$72.11 - $85.47 $378,072 - $448,119	5,243	5,243 $425,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account